National Health Act (Pharmaceutical Benefits – Early Supply) Amendment October 2011 - specification under subsection 84AAA(2) (No. PB 73 of 2011) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 73 of 2011
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment October 2011 - specification under subsection 84AAA(2)1
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 28 Sep 2011
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — Pharmaceutical Benefits - Early Supply
1 Name of Instrument
(1) This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment October 2011 - specification under subsection 84AAA(2).
(2) This Instrument may also be cited as No. PB 73 of 2011.
2 Commencement
This Instrument commences on 1 October 2011.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.
Schedule 1 Amendments
Schedule 1, entry for Degarelix
omit from the column headed “LI Form and Strength”: Powder for injection 80 mg (as acetate) with solvent, syringe and needles
substitute: Powder for injection 80 mg (as acetate), injection set
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0